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High O2 consumption, modest antioxidant defenses and a 
lipid-rich constitution make the brain highly vulnerable to redox 
imbalances. Oxidative damage in the brain causes nervous system 
impairment. Recently, oxidative stress has also been implicated 
in  depression,  anxiety  disorders  and  high  anxiety  levels.  The 
findings which establish a link between oxidative stress and path-
ological anxiety have inspired a number of other recent studies 
focusing on the link between oxidative status and normal anxiety 
and also on a possible causal relationship between cellular oxida-
tive stress and emotional stress. This review examines the recent 
discoveries made on the link between oxidative status and normal 
anxiety levels and the putative role of oxidative stress in genesis 
of anxiety. We discuss the different opinions and questions that 
exist in the field and review the methodological approaches that 
are being used to determine a causal relationship between oxida-
tive and emotional stress.
Introduction
Anxiety  is  an  aversive  emotional  state,  in  which  the  feeling 
of  fear  is  disproportionate  to  the  nature  of  the  threat.1  In 
response to threatening situations, the feeling of the emotion that 
constitutes  the  subjective  feature  of  anxiety  is  accompanied  by 
emotional stress, which involves behavioral, expressive and physi-
ological features, such as an avoidance of the source of the danger, 
assuming defensive postures and an increase in blood pressure, 
respectively.1,2 Anxiety is a normal emotional response to a threat 
or potential threat. When this emotion is inappropriate, extreme 
and persistent, it is classified as pathological.1,3 Anxiety is impli-
cated in a number of psychiatric disorders, such as depression, 
panic  attacks,  phobias,  generalized  anxiety  disorder,  obsessive-
compulsive disorder and post-traumatic stress disorder.3 Anxiety 
disorders  affect  approximately  28.8%  of  the  US  population,4 
imposing both an individual and a social burden that amounts to 
a total cost of $42.3 billion in the US in 1990.5 Anxiety disorders 
are the most common class of psychiatric disorders in the US4 and 
many other countries.6 According to an ESEMeD study including 
six European countries, the 12-month prevalence of inappropriate 
anxiety was 6.4%.7 In the most recent systematic review of studies 
conducted  in  16  European  countries,  however,  this  value  was 
estimated to be 12%.8 In an obese population in the UK, 56% of 
patients met the minimum criteria for an anxiety disorder.9 It is 
estimated that one-eighth of the total population worldwide suffers 
from inappropriate anxiety.10 Population-based studies have shown 
that anxiety disorders frequently go untreated.11,12 Predominantly, 
the research that has been performed on anxiety has focused on 
the regulatory systems, including gamma-aminobutyric acidergic 
(GABAergic) and serotoninergic systems among others. However, 
Kuloglu et al.13,14 recently established a link between oxidative 
stress and certain anxiety disorders (obsessive-compulsive disorder 
and panic disorder), demonstrating that other systems, such as 
oxidative metabolism, can affect the regulation of anxiety. These 
findings, which establish a link between oxidative stress and patho-
logical anxiety, inspired a number of other recent studies focusing 
on the link between oxidative status and normal anxiety (Table 1) 
and also on a possible causal relationship between cellular oxidative 
stress and emotional stress.
It  is  well  known  that  low/moderate  concentrations  of  reac-
tive oxygen species (ROS) affect a great number of physiological 
functions.15 However, when ROS concentration exceeds the anti-
oxidative capacity of an organism, animal cells enter a state termed 
oxidative stress, in which the excess ROS induces oxidative damage 
on cellular components.15,16 As a result, oxidative stress has been 
implicated in a large range of diseases, including cancer, diabetes, 
male infertility, autoimmune diseases, atherosclerosis and cardio-
vascular disorders.15-17
The brain is highly vulnerable to oxidative stress due to its high 
O2 consumption, its modest antioxidant defenses and its lipid-rich 
constitution.18,19 Human brain utilizes 20% of oxygen consumed 
by the body even though this organ constitutes only about 2% 
of the body weight.19,20 When the production of oxygen-derived 
metabolites prevails over the brain defense systems, however, oxida-
tive damage to nucleic acids, proteins and neuronal membrane 
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A  link  between  oxidative  stress  and  emotional  stress  is  not 
surprising, since it is well accepted that oxidative damage in the 
brain causes an impairment of the nervous system. In living organ-
isms, an imbalance between oxidant production and antioxidant 
protection  that  favors  oxidants  causes  a  state  termed  oxidative 
stress.  In  this  state,  there  can  be  differences  gene  expression, 
protein conformation and cellular signaling. This state may also 
alter  neurotransmission,  neuronal  function  and  overall  brain 
activity, as well as disrupting membrane integrity; even neuronal 
cell  death  may  result.15,16,21,22  Most  studies  have  shown  that 
anxiety is controlled by the nervous system and that GABAergic 
and serotoninergic systems play   important roles in the regulation 
of anxiety.1,26 Abnormalities in these regulatory systems in rodents, 
which are used as translational models for human anxiety,25,27,28 
can  result  in  anxious  behavior.26  Altering  the  function  of  the 
hypothalamic-pituitary-adrenal  (HPA)  axis,  which  is  implicated 
in stress responses29 and anxiety disorders, could also impact the 
emotional response.29,30
Nevertheless,  Hovatta  et  al.25  obtained  surprising  results  in 
a  genetic  manipulation  using  lentivirus-mediated  gene  transfer: 
local overexpression of glutathione reductase 1 and glyoxalase 1 in 
the cingulated cortex of the murine brain results in an increase of 
anxiety-like behavior, while inhibition of glyoxalase 1 expression 
produces low-anxiety mice. Thus, Hovatta et al.25 were able to 
make a causal link between the antioxidative status of the brain 
and  anxiety-related  behavior  and  hypothesize  that  glyoxalase  1 
and glutathione reductase 1 regulate anxiety in mice. It is worth 
mentioning that in vivo, antioxidant genes are overexpressed in 
response to an uncontrolled production of ROS. Indeed, in vivo, 
excessive  ROS  accumulation  induces  the  overexpression  of  the 
glutathione redox system, including glutathione reductase, and a 
general  overexpression  of  endogenous  antioxidants.31,32  In  the 
lipids, which are rich in highly polyunsaturated fatty acids, can 
occur.15,16,19 In presence of oxidative stress, the lipid-rich consti-
tution of brain favors lipid peroxidation that results in decrease in 
membrane fluidity and damage in membrane proteins inactivating 
receptors, enzymes and ion channels.15,16,19 As a result, oxidative 
stress can alter neurotransmission, neuronal function and overall 
brain  activity.16,21,22  Oxidative  stress  has  been  associated  with 
several diseases which are specific for nervous system impairment 
including neurodegenerative diseases and neuropsychiatric diseases, 
such as schizophrenia and major depressive disorder.15,16,23,24 The 
intrinsic oxidative vulnerability of the brain has led some authors 
to suggest that oxidative damage may be a plausible pathogenic 
factor for certain neurological diseases including neuropsychiatric 
disorders.18
In this review, we discuss the relationship between oxidative 
stress and normal anxiety by presenting the recent advances in the 
field and the different views that exist. We also review the method-
ological approach for determining the causal relationship between 
oxidative stress and emotional stress.
A Link Between Oxidative Stress Metabolic Pathways and 
Anxiety-Related Phenotypes
In 2005, Hovatta et al.25 identified a close relationship between 
antioxidative defense mechanisms and anxiety-related phenotypes 
in six inbred mouse strains. They found that, in the brain, the 
expression of glutathione reductase 1 and glyoxalase 1, which are 
genes involved in antioxidative metabolism, is highly correlated 
with  anxiety-related  phenotypes.  Furthermore,  they  also  found 
that the activity of these enzymes is highest in the most anxious 
mice and lowest in the least anxious strains. These authors were 
the first to demonstrate a link between oxidative stress metabolic 
pathways and normal anxiety.
Table 1    Data establishing the link between pathological/normal anxiety and oxidative cell pathways 
and mechanisms
      Indirect evaluation of    Direct evaluation of 
      oxygen-derived species    oxygen-derived species 
          Subjects    Expression of  Activity of  Lipid peroxidation  Intracellular ROS levels assessed 
    antioxidant genes  antioxidant proteins  markers  by using the 2',7'-dichlorofluorescin 
          diacetate (DCFH-DA) sensor
Pathological  Patients with  -  In erythrocytes:  In plasma: 
anxiety  obsessive-compulsive   Superoxide dismutase*,  Malondialdehyde*  - 
  disorder and panic    catalase, glutathione 
  disorder Vs. healthy    peroxidase* 
  controls 
  (Kuloglu et al.13,14)
Normal   Mouse strains with high-   In brain:  In brain: 
trait-anxiety  Vs. low-anxiety-  Glyoxalase 1* and  Glyoxalase 1* and   -  - 
  related phenotypes  glutathione  glutathione  
  (Hovatta et al.25)  reductase 1*   reductase 1*
  Anxious Vs. non-anxious  -  -  -  In brain and 
  Swiss albino mice         peripheral cells: 
  (Rammal et al.41,42)        Neurones*, glial cells*, 
          granulocytes*, monocytes* 
           and lymphocytes*
*significantly different from controls (healthy humans, strains with low-anxiety-related phenotypes, non anxious mice).Oxidative stress and anxiety: Relationship and cellular pathways
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trait anxiety.33,34 These results are discordant with those 
of Hovatta et al.25 however, and complicate the under-
standing of the relationship between oxidative stress and 
trait anxiety. Krömer et al.33 and Ditzen et al.34 examined 
the expression of glyoxalase 1 in several areas of the brain 
areas and in red blood cells and found that this protein is 
expressed more in a line with a low-anxiety-related behav-
ioral phenotype than in a line with a high-anxiety-related 
behavioral  phenotype.  It  is  worth  noting  that  Hovatta   
et al.25suggested that there is a link between glyoxalase 1 
and oxidative stress but that this link is indirect.35 Indeed, 
glyoxalase 1 is an enzyme of the glyoxalase system, which 
protects against carbonyl stress; glutathione is a determi-
nant cofactor for the enzymatic reaction that is catalyzed 
by glyoxalase 1.35-37
A Link Between Oxidative Stress Metabolic Pathways 
and Anxiety-Related Behavior
The  disagreements  in  the  data  of  Hovatta  et  al.25, 
Krömer et al.33 and Ditzen et al.34 can be partly explained 
by the differences in the genotypes of the strains.35 Thus, 
it would be interesting to compare in the same strain the 
oxidative status of mice with contrasting levels of anxiety, 
rather than compare the oxidative status of strains that differ 
in their anxiety-related phenotypes. We have observed that 
naive Swiss albino male mice have a large heterogeneity 
in their anxiety levels.38 In first order regression analyses 
of the performances of mice in the light/dark choice test, 
which are used as a behavioral indices of anxiety, and the 
intracellular ROS accumulation in blood granulocytes, we 
found correlation coefficients (R2) ranging from 0.61 (p < 
0.01) to 0.73 (p < 0.001) (Fig. 1). Our results suggest that 
there is a positive correlation between peripheral blood cell 
oxidative status and anxiety-related behavior in the light/
dark box in Swiss albino male mice.38
Levels of ROS can be evaluated directly with sensors, 
such  as  2’,7’-dichlorofluorescin  diacetate  (DCFH-
DA),39,40 or indirectly by measuring the levels of certain 
antioxidant enzymes, byproducts of lipid peroxidation or 
some transition metals, such as copper, zinc and iron.13,14 
In  our  study,  the  intracellular  redox  status  of  the  cells 
was evaluated using the tracer DCFH-DA, a well known 
sensor of ROS.39,40 To confirm the relationship between 
oxidative  stress  and  emotional  stress,  we  comparatively 
evaluated the peripheral oxidative status of mice with contrasting 
levels of anxiety (anxious and non-anxious). Mice with interme-
diate  behaviors  were  eliminated.41 We  found  that  high  anxiety 
in  mice  in  the  light-dark  box  is  accompanied  by  significantly 
high levels of intracellular ROS in lymphocytes, granulocytes and 
monocytes (Table 2). Our results confirm that there is the relation-
ship between the level of intracellular ROS in peripheral blood 
cells and anxiety-related behavior in mice.41
These  results  prompted  us  to  study  the  oxidative  status  of 
the  brain  in  mice  with  contrasting  levels  of  anxiety.  Using 
the same behavioral approach to distinguish between anxious and 
lentivirus experiments of Hovatta et al.25, however, the overexpres-
sion of the transgenes (glyoxalase 1 and glutathione reductase 1) 
was induced in vivo with a lentiviral vector and not an excessive 
production of toxic oxygen metabolites. Clearly, the mechanism by 
which these enzymes regulate anxiety is of great interest.26
During the same period in which the Hovatta et al.25 study was 
being conducted, other studies were performed on two Swiss CD1 
mouse lines with contrasting anxiety-like behavioral phenotypes. 
These mice were generated from wild type mice after >15 genera-
tions of selection. Results from these studies have led researchers 
to  propose  that  glyoxalase  1  might  be  a  biological  marker  for 
Figure 1. Linear correlation between intracellular redox status and different param-
eters used for assessment of anxiety-related behavior in mice (n = 18). Correlation of 
peripheral blood granulocyte oxidative status with latency of first crossing from dark 
to lit box (A), time spent in lit box (B) and number of transitions between two boxes 
(C), respectively. Fluorescence intensity (FI) expressed as a decimal logarithm. FI 
emitted by granulocytes is due to oxidation of intracellular DCFH-DA by ROS (data 
published by Bouayed et al.38 in Eur J Pharmacol).Oxidative stress and anxiety: Relationship and cellular pathways
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anxious  behavior  through  the  NADPH  oxidase  pathway.  The 
anxiogenic  behavior  due  to  BSO  treatment  was  observed  in 
several mouse models of anxiety, including elevated plus maze, 
hole-board and open field tests. Masood et al.29 induced oxida-
tive stress in mice by depleting glutathione with BSO inhibition 
of  gamma-glutamylcysteine  synthetase.  Glutathione  depletion 
causes a myriad of cellular stresses, including oxidative, nitrosative 
and carbonyl stresses, as glutathione is an important determinant 
of  the  oxygen,  nitrogen  and  dicarbonyl  metabolisms.15,16,35,44 
Excessive production of ROS induces oxidative damage of cellular 
structures;15,16,19,45 production of reactive nitrogen species triggers 
nitrosylation reactions, which can alter the structure of proteins 
to  inhibit  their  normal  function;15,16,46  excessive  accumulation 
of reactive dicarbonyl compounds leads to damage of protein and 
nucleotides by dicarbonyl glycation.35-37
Indirect Evidence for the Causal Link Between Oxidative 
Stress and Anxiety
Recent data from Desrumaux et al.47, Souza et al.48 and Berry 
et  al.49  provide  indirect  evidence  for  the  causal  link  between 
oxidative stress and anxiety-related behavior. Desrumaux et al.47 
showed that vitamin E deficiency in the mouse brain significantly 
increases the levels of central oxidative stress markers, resulting 
in anxiogenic behavior without abnormalities in the locomotor 
performance of the mice. Souza et al.48 demonstrated in rats that 
the consumption of a highly palatable diet enriched with sucrose 
leads to an obese phenotype, increases protein oxidation in the 
frontal  cortex  and  induces  anxiety-like  behavior  in  the  dark/
light choice test without altering locomotion in an open field 
test. Berry et al.49 showed that mice developed anxious behavior 
during aging, likely due to the accumulation of oxidative damage, 
which  is  a  characteristic  of  the  aging  process  in  animals.50,51 
In addition, Berry et al.49 showed that a deletion of the p66Shc 
longevity gene in mice, which results in lower levels of oxida-
tive  stress  and  an  extended  life  span,  decreases  anxiety-related 
behavior. Overall, the data presented in these reports suggest that 
oxidative stress can provoke anxious behavior in rodents.
Conclusion
This  review  summarizes  the  data  to  support  a  link  between 
oxidative stress and anxiety. While all of the data demonstrate that 
there is a link between oxidative stress and high-anxiety-related 
behavior, a cause-effect relationship has yet to be completely estab-
lished. Some of these studies suggest that oxidative stress causes 
anxiety-related behaviors but do not explain the underlying mecha-
nisms. While there are some limits in the approach to establish the 
anxiogenic effect of oxidative stress, the available data are consis-
tent this causal relationship. The potential causal role of oxidative 
stress on anxiety may generate interest in antioxidants. Masood et 
al.29 were able to show that oxidative stress-related anxiety can be 
reversed in mice upon inhibition of NADPH oxidase or phospho-
diesterase-2, enzyme that is indirectly implicated in oxidative stress 
mechanisms. Surprisingly, they found that diazepam, which is a 
well known anxiolytic, does not fully reverse the oxidative stress-
related anxiety. These results point to a possible use for antioxidants 
non-anxious mice, we found that anxiety in mice is accompanied 
by markedly elevated levels of ROS in neuronal and glial cells 
within the cerebellum and hippocampus, as well as in neurons 
of the cerebral cortex and in blood monocytes, granulocytes and 
lymphocytes  (Table  3).  As  a  consequence,  we  suggest  that  an 
imbalance in the redox system of anxious mice plays a role in 
neuroinflammation and neurodegeneration, predisposing them to 
recurrent infection and chronic inflammation.42 The results of our 
studies38,41,42 are in good concordance with the initial findings of 
Hovatta et al.25 and show a clear link between oxidative stress and 
trait anxiety, but our findings do not permit us to declare a causal 
relationship between these stresses.
In agreement with our recent findings,41,42 Yasunari et al.43 
observed a significant relationship between trait anxiety and ROS 
formation  in  monocytes  of  hypertensive  individuals.  Recently, 
Masood et al.29 published work that contributes to the under-
standing of the relationship between oxidative stress and anxiety. 
They examined the direct effect of oxidative stress on anxiety-like 
behavior and established that oxidative stress leads to anxiogenic 
behavior in mice. They found that treating mice with buthionine-
S,R-sulfoximine  (BSO),  an  inducer  of  oxidative  stress,  induces 
Table 2    Intracellular ROS accumulation in peripheral 
immune cells of anxious and non-anxious mice
  Mean fluorescent intensity (arbitrary units)
Type of cells  Anxious mice  Non-anxious mice
Lymphocytes  215 ± 31*  135 ± 12
Monocytes  46 ± 8*  25 ± 4
Granulocytes  1635 ± 375**  418 ± 87
The  mean  fluorescent  intensity  corresponds  to  fluorescence  resulting  from  intracellular  DCFH-DA  
oxidation by intracellular ROS. Data are expressed as mean ± SEM. (n = 10). *p < 0.05; **p < 0.01. 
(data published by Rammal et al.41 in Eur J Pharmacol).
Table 3    Intracellular ROS accumulation in cerebral and 
peripheral cells of anxious and non-anxious 
mice
  Mean fluorescent intensity (arbitrary units)
Type of cells  Anxious mice  Non-anxious mice
Neurons of cerebral cortex  1223 ± 232**  177 ± 76
Neurons of cerebellum  546 ± 128*  227 ± 41
Neurons of hippocampus  1749 ± 566*  227 ± 51
Glial cells of cerebral cortex  429 ± 48  310 ± 72
Glial cells of cerebellum  343 ± 36*  195 ± 31
Glial cells of hippocampus  468 ± 43*  319 ± 29
Lymphocytes  251 ± 46*  152 ± 11
Monocytes  56 ± 9*  35 ± 2.5
Granulocytes  1979 ± 405**  448 ± 77
The mean fluorescent intensity corresponds to fluorescence resulting from intracellular DCFH-DA oxida-
tion by intracellular ROS. Data are expressed as mean ± SEM. (n = 10). *p < 0.05; **p < 0.01.  
(data published by Rammal et al.42 in Brain Behav Immun).Oxidative stress and anxiety: Relationship and cellular pathways
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in the prevention or reduction of high anxiety. Further research will 
be necessary to show whether anxious subjects need more antioxi-
dants than non-anxious subjects. Recent work52,53 has shown that 
some  dietary  polyphenols  have  both  anxiolytic  and  antioxidant 
effects, which may be beneficial to anxious subjects.
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